arrow
Back
B

Bruno Sangro

Clinica Universidad de Navarra and Ciberehd

95H-index
815Paper Count
4.8WCitation Count
Published Papers 284
Publication Date
err2026-07-25
err0
PREAI
errStephen L. Chan; Bruno Sangro; Lorenza Rimassa
errShare
errSave
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma
err2026-03-31
err0
errOAAI
errElena Adan-Villaescusa; Borja Castello-Uribe; Iker Uriarte; Eva Santamaria; Roberto Barbero; Miriam Belzunce; Amaya López-Pascual; Maria Ujue Latasa; Jasmin Elurbide; Emiliana Valbuena-Goiricelaya; Agavni Mesropian; Guillem Cano-Segarra; Ana Hernández de Sande; Lorenzo Nevi; Simone Carotti; Umberto Vespasiani-Gentilucci; Felipe Prosper; Antonio Pineda-Lucena; Bruno Sangro; Josepmaria Argemi
errShare
errSave
Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy
err2026-03-18
err0
errOAAI
errBelén Aparicio; Leyre Silva; Marta Ruiz; Diana Llópiz; David Repáraz; Patrick Theunissen; Ibon Tamayo; Josune Egea; Ana Igea; Cristian Smerdou; Maria Peñas; Cristina Perpiñá; Ana Matilla; María Varela; Maria Reig; Manuel de la Torre-Alaez; Josepmaria Argemí; Bruno Sangro; Sandra Hervás-Stubbs; Pablo Sarobe
errShare
errSave
Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma
err2026-03-13
err0
errOAAI
errLuz A. Martínez-Pérez; M. Ujue Latasa; Iker Uriarte; Amaya López-Pascual; Jasmin Elurbide; Pavel Strnad; Sona Frankova; Eva Sticova; Ondrej Fabian; Maria Arechederra; Eva Santamaria; Josepmaria Argemi; Bruno Sangro; Beatrice Foglia; Maurizio Parola; Melva Gutiérrez-Angulo; Stefano Cairo; Ramón Bataller; Pau Sancho-Bru; Maria L. Martinez-Chantar; Jose J. G. Marin; Andrea Castaneda; Carolina Armengol; Carmen Berasain; Maite G. Fernandez-Barrena; Matias A. Ávila
errShare
errSave
A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells
err2025-12-19
err0
errOAAI
errNicolaas Van Renne; Fleur Ballet; Stijn Van Hees; Bart Cuypers; Arno Furquim d’Almeida; Axelle Vanderlinden; Pieter Meysman; Jordan J. Feld; Paloma Sangro del Alcázar; Stefan Bourgeois; Dirk Sprengers; Geert Robaeys; Luisa Vonghia; Peter Michielsen; Sven Francque; Bruno Sangro; Owen Cain; Ahmed M. Elsharkawy; Rob De Man; Andre Boonstra
errShare
errSave
Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis
err2025-12-01
err0
errOAAI
errChan, Stephen Lam; Kudo, Masatoshi; Sangro, Bruno; Kelley, Robin Kate; Kim, Jee Hyun; Pham, Binh; Hong, Jung Yong; Waldschmidt, Dirk-Thomas; Marino, Donatella; Lee, Jie Xin Joycelyn; Gerolami, Rene; Burgoyne, Adam M.; Li, Qiao; Nakamura, Hitomi; Sun, Peng; Baur, Boris; Rimassa, Lorenza
errShare
errSave
In vitro and in silico assessment of a multi side-hole catheter for transcatheter endovascular treatments on arterial bifurcations
err2025-11-28
err0
errOAAI
errJulio Ortega; Raúl Antón; Juan.C. Ramos; Alejandro Rivas; Gorka.S. Larraona; Bruno Sangro; José I. Bilbao; Jorge Aramburu
errShare
errSave
Response evaluation to systemic therapy in HCC: Current challenges and future perspectives
err2025-11-01
err0
PREAI
errMatute-Gonzalez, Mario; Ronot, Maxime; Chernyak, Victoria; Sangro, Bruno; Rimola, Jordi
errShare
errSave
Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
err2025-10-31
err0
errOAAI
errOsman Öcal; Christoph Johannes Zech; Maria Antonietta Bali; David Pasquier; Felix Mottaghy; Ingo Einspieler; Nikolaos Kartalis; Irene Bargellini; Roberto Iezzi; Timm Denecke; Wolfgang Gerhard Kunz; Bernhard Gebauer; Henning Wege; Roberto Cannella; Daniela Elena Oprea-Lager; Arndt Vogel; Bruno Sangro; Max Seidensticker
errShare
errSave
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update
err2025-10-27
err0
PREAI
errMaria Reig; Marco Sanduzzi-Zamparelli; Alejandro Forner; Jordi Rimola; Joana Ferrer-Fàbrega; Marta Burrel; Ángeles Garcia-Criado; Alba Díaz; Neus Llarch; Gemma Iserte; Meritxell Mollà; Robin K. Kelley; Peter R. Galle; Vincenzo Mazzaferro; Riad Salem; Bruno Sangro; Amit Singal; Arndt Vogel; Ted K. Yanagihara; Carmen Ayuso; Ferran Torres; Jordi Bruix
errShare
errSave
Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?
err2025-08-29
err0
errOAAI
errLucía Ceniceros; Manuel de La Torre; Ana Landa Magdalena; Paloma Sangro; Josepmaria Argemí; Delia D’Avola; Bruno Sangro; Mariano Ponz-Sarvisé
errShare
errSave
Tremelimumab for the treatment of hepatocellular carcinoma
err2025-08-21
err0
PREAI
errMiguel Sogbe; Paloma Sangro; Manuel de la Torre-Aláez; Bruno Sangro
errShare
errSave
Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association
err2025-07-31
err0
PREAI
errManon Allaire; Leonardo G. Da Fonseca; Marco Sanduzzi-Zamparelli; Won-Mook Choi; Cecilia Monge; Ken Liu; Michael Leibfried; Sarah Manes; Zorana Maravic; Milan Mishkovikj; Jordi Bruix; Helen L. Reeves; Riad Salem; Bruno Sangro
errShare
errSave
Expression landscape of epigenetic genes in human hepatocellular carcinoma
err2025-06-12
err0
errOAAI
errBorja Castelló-Uribe; Amaya López-Pascual; Jasmin Elurbide; Elena Adán-Villaescusa; Emiliana Valbuena-Goiricelaya; Luz A. Martinez-Perez; Iker Uriarte; M. Ujúe Latasa; Bruno Sangro; María Arechederra; Carmen Berasain; Matías A. Avila; Maite G. Fernández-Barrena
errShare
errSave
Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
err2025-05-23
err0
errOAAI
errOecal, Osman; Zech, Christoph Johannes; Bali, Maria Antonietta; Pasquier, David; Mottaghy, Felix; Einspieler, Ingo; Kartalis, Nikolaos; Bargellini, Irene; Iezzi, Roberto; Denecke, Timm; Kunz, Wolfgang Gerhard; Gebauer, Bernhard; Wege, Henning; Cannella, Roberto; Oprea-Lager, Daniela Elena; Vogel, Arndt; Sangro, Bruno; Seidensticker, Max
errShare
errSave
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC
err2025-04-11
err0
errOAAI
errLorenza Rimassa; Stephen L. Chan; Bruno Sangro; George Lau; Masatoshi Kudo; Maria Reig; Valeriy Breder; Min-Hee Ryu; Yuriy Ostapenko; Wattana Sukeepaisarnjaroen; Maria Varela; David Tougeron; Oxana V. Crysler; Mohamed Bouattour; Tu Van Dao; Vincent C. Tam; Adilson Faccio; Junji Furuse; Long-Bin Jeng; Yoon Koo Kang; Robin K. Kelley; Michael J. Paskow; Di Ran; Ioannis Xynos; John F. Kurland; Alejandra Negro; Ghassan K. Abou-Alfa
errShare
errSave
Transarterial chemoembolisation with irinotecan (irinotecan-TACE) as salvage or post-inductive therapy for colorectal cancer liver metastases: effectiveness results from the CIREL study
err2025-03-01
err0
PREAI
errArnold, D.; Pereira, P. L.; Iezzi, R.; Gjoreski, A.; Spiliopoulos, S.; Helmberger, T.; Gomez, F. M.; de Baere, T.; Pellerin, O.; Maleux, G.; Prenen, H.; Sangro, B.; Zeka, B.; Kaufmann, N. C.; Taieb, J.
errShare
errSave